Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2021-07-05

Original market date: See footnote 1

2021-07-05

Product name:

WAYMADE-TRIENTINE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02515067

Product Monograph/Veterinary Labelling:

Date: 2021-04-19 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

WAYMADE PLC
Sovereign House, Miles Gray Road
Basildon
Essex
United Kingdom  SS14 3FR

Class: 

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

64:00.00   HEAVY METAL ANTAGONISTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

A16AX12  TRIENTINE

Active ingredient group (AIG) number:See footnote 5

0162478001

List of active ingredient(s)
Active ingredient(s) Strength
TRIENTINE HYDROCHLORIDE 250 MG

Risk Management Plans See footnote 7

A Risk Management Plan (RMP) for this product was submitted.

Application information

Related information

Contact us

Version 3.9.1
Date modified: